1. |
Omata F, Deshpande G, Tokuda Y, et al. Metaanalysis: somatostatin or its longacting analogue, octreotide, for prophylaxis against postERCP pancreatitis [J]. J Gastroenterol, 2010, 45(8): 885895.
|
2. |
Chen P, Hu B, Tan Q, et al. Role of neurocrine somatostatin on sphincter of Oddi contractility and intestinal ischemia reperfusioninduced acute pancreatitis in macaques [J]. Neurogastroenterol Motil, 2010, 22(8): 935941.
|
3. |
Weber C, Zulian GB. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics [J]. Am J Hosp Palliat Care, 2009, 26(2): 8488.
|
4. |
Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction [J]. Eur J Cancer, 2008, 44(8): 11051115.
|
5. |
郭鷂. 人類疾病的動物模型 [M]. 北京: 人民衛生出版社, 1982: 302305.
|
6. |
田永立, 李家邦. 清肝利濕湯治療膽囊炎膽石癥的實驗研究 [J]. 湖南中醫學院學報, 1999, 19(3): 57, 9.
|
7. |
陶興和. 急性膽囊炎患者膽汁細菌培養及藥物敏感試驗分析 [J]. 中國全科醫學, 2009, 12(6B): 10861087.
|
8. |
胡蓉, 盛宇偉, 王傳海. 198例急性膽囊炎手術膽汁需氧菌培養與抗生素選用臨床研究 [J]. 中國藥房, 2008, 19(29): 22742276.
|
9. |
陳美華, 王瑤瑤, 龐桂蘭. 128例急性膽囊炎患者膽汁細菌培養分析 [J]. 醫學綜述, 2009, 15(20): 31853187.
|
10. |
張永杰. 膽囊、膽總管結石患者與對照者膽囊膽汁及膽總管膽汁的同步細菌學檢測分析 [J]. 國外醫學外科學分冊, 1996, 23(6): 370371.
|
11. |
Opal SM. Tumor necrosis factor receptor expression on inflammatory cells in sepsis [J]. Crit Care Med, 1999, 27(2): 240241.
|
12. |
Maier B, Lehnert M, Laurer HL, et al. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury [J]. Shock, 2006, 26(2): 122127.
|
13. |
徐延鈞, 吳新民, 郭亞民. 腫瘤壞死因子α及白介素在急性胰腺炎中的作用 [J]. 中國普外基礎與臨床雜志, 2010, 17(9): 993996.
|
14. |
Brunkhorst FM. Sepsismarker—what is useful? [J]. Dtsch Med Wochenschr, 2008, 133(48): 25122515.
|
15. |
Szalai AJ. The biological functions of Creactive protein [J]. Vascul Pharmacol, 2002, 39(3): 105107.
|
16. |
Ohtani T, Hirayama A, Kodama K. Clinical value of biochemical markers in patients with unstable angina [J]. Nippon Rinsho, 2003, 61 Suppl 5: 200205.
|
17. |
Gould JM, Weiser JN. The inhibitory effect of Creactive protein on bacterial phosphorylcholine plateletactivating factor receptormediated adherence is blocked by surfactant [J]. J Infect Dis, 2002, 186(3): 361371.
|
18. |
Tilg H, Vannier E, Vachino G, et al. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL1) receptor antagonist over IL1 beta synthesis by human peripheral blood mononuclear cells [J]. J Exp Med, 1993, 178(5): 16291636.
|
19. |
Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by Creactive protein [J]. Cytokine, 1992, 4(5): 361368.
|
20. |
劉曉毅, 楊林, 祁光裕, 等. 白介素、C反應蛋白和纖維蛋白原在下肢深靜脈血栓炎癥反應中的作用 [J]. 中國普外基礎與臨床雜志, 2010, 17(7): 660663.
|
21. |
Burdon D, Zabel P. Acute phase reaction and immunocompetence in sepsis and SIRS [J]. Wien Klin Wochenschr, 2002, 114 Suppl 1: 18.
|
22. |
Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive [J]. Am J Respir Crit Care Med, 2001, 163(2): 316321.
|
23. |
張穎, 于學忠. 急性重癥胰腺炎患者生長抑素干預前后pHi監測及其臨床意義 [J]. 中國危重急救醫學, 2002, 14(6): 368370.
|
24. |
吳碩東, 張振海, 金俊哲,等. 影響奧狄括約肌運動功能藥物的膽道鏡測壓研究 [J]. 中華醫學雜志, 2005, 85(27): 19111915.
|
25. |
李延鈞, 吳碩東. 生長抑素對Oddi’s括約肌功能的影響 [J]. 肝膽胰外科雜志, 2005, 17(2): 126128.
|